Barely Significant
← all excerpts

Novel sporozoite-based ELISpot assay to assess frequency of parasite-specific B cells after vaccination with irradiated sporozoites.

Malar J · 2019 · PMC6540377 · PMID 31142328

1
hedged sentence
0.0800
closest p · 1.6× alpha
0.0800
boldest claim

The sentences

a strong trendp = 0.08so close (0.05 < p ≤ 0.1)
While the data confirm that CSP is one of the major antigens recognized by malaria-immune B cells, they also show that other sporozoite-specific antigens are present and recognized by a significantly higher number of B cells; (b) the frequency of CSP-specific B cells is significantly higher in subjects protected by the RAS vaccine (p = 0.016, 2-sided T-test); (c) the frequency of sporozoite-specific B cells has a strong trend to be higher in protected subjects (p = 0.08, 2-sided T-test).

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.